Antibody Raw Material · OEM Ready

SP10 FIA Test

Quantitative Fluorescent Immunoassay for Male Fertility Assessment

FIA POCT Male Fertility SP10 / ACRV1 OEM
0.6
ng/mL Lowest Calibrator
≤7.3%
Within-Run CV
~9,700×
Clinical Group Separation
4+
Log Dynamic Range

Precision Quantification of Sperm-Specific SP10

The SP10 FIA Test is a high-performance fluorescent immunoassay for the quantitative measurement of SP10 — the sperm-specific acrosomal membrane glycoprotein (ACRV1) — in human semen. As SP10 is expressed exclusively by spermatozoa and absent from all somatic cells, it provides a highly specific, objective biomarker for male fertility assessment.

Built on a validated anti-SP10 monoclonal antibody pair optimized for fluorescence lateral flow platforms, this assay delivers quantitative results across a wide dynamic range and demonstrates complete clinical separation between azoospermic and normozoospermic individuals — with no overlap observed in clinical validation samples.

Fluorescence LFA Sandwich Immunoassay ISO 13485 Manufacturer OEM Antibody Pair Available

Analytical Specifications

Assay Format Fluorescent Immunoassay (FIA)
Target Antigen SP10 / ACRV1
Sample Type Human Semen
Detection Range 0.6 – 10,000 ng/mL
S/N at Lowest Calibrator 9 (at 0.6 ng/mL)
Within-Run CV ≤ 7.3%
Antibody Format Anti-SP10 Monoclonal Pair
Clinical Separation ~9,700× (mean conc.)

Built for Diagnostic Performance

Six engineering priorities that make this antibody pair the right choice for your platform.

Wide Dynamic Range

Calibrated from 0.6 to 10,000 ng/mL — over 4 decades — enabling a single assay to cover the full clinical spectrum from severely oligozoospermic to hyperfertile samples.

High Signal-to-Noise

S/N of 9 at the lowest calibrator (0.6 ng/mL), rising to over 10,000 at the upper range — delivering confident detection even at minimal antigen concentrations.

Excellent Precision

Within-run CV ≤ 7.3% across two clinically relevant concentrations (16 and 400 ng/mL, n = 10), well within IVD precision requirements.

Sperm-Specific Target

SP10 (ACRV1) is expressed exclusively in post-meiotic spermatids. Zero cross-reactivity with somatic cell proteins eliminates background interference from non-sperm material.

Strong Clinical Evidence

Validated on clinical semen samples from confirmed azoospermic patients and normal fertile males, demonstrating complete separation with no overlap between groups.

OEM & Platform Ready

Antibody pair is available as raw material for licensed IVD manufacturers. Compatible with FIA strip and ELISA formats; optimized for fluorescence reader-based systems.

Analytical & Clinical Data

All data generated using Sekbio's anti-SP10 monoclonal antibody pair in an FIA sandwich format.

1 Analytical Sensitivity — Calibration Curve

Eight calibrators spanning 0.6 to 10,000 ng/mL demonstrate a robust dose-response relationship. The blank (S1) produces a near-zero T/C of 0.001, confirming negligible non-specific signal. Detection at 0.6 ng/mL achieves an S/N of 9, well above the conventional LoD threshold (S/N ≥ 3).

Calibrator Concentration (ng/mL) Run 1 — T/C Run 2 — T/C Avg. T/C S/N vs. Blank
S1 — Blank0.0010.0010.001
S20.60.0080.0080.0089
S33.20.0390.0340.03743
S416.00.1930.1890.191226
S5801.0030.9660.9841,165
S64003.2103.2173.2143,803
S72,0007.0146.9406.9778,257
S810,0009.4928.8829.18710,872
T = Test line fluorescence; C = Control line fluorescence; T/C = signal ratio; S/N = signal-to-noise ratio vs. blank (S1).
2 Precision — Within-Run Repeatability

Repeatability was assessed at two clinically relevant concentrations across 10 replicates each. Both levels achieve CV values well within the IVD precision acceptance criterion of ≤ 10%.

Concentration (ng/mL) Replicates (n) Min T/C Max T/C Avg. T/C CV (%)
16100.1750.2190.1917.3%
400100.7123.2912.9546.1%
Acceptance criterion: CV ≤ 10% (IVD industry standard).
3 Clinical Performance — Azoospermic vs. Normal Male

The assay was evaluated on de-identified clinical semen samples from confirmed azoospermic patients (n = 10) and normal fertile males (n = 10). Results demonstrate complete, non-overlapping separation between groups.

Azoospermic

n = 10 confirmed azoospermic patients

T/C Range 0.01 – 0.08
SP10 Conc. Range 0.02 – 0.68 ng/mL
Mean Concentration 0.18 ng/mL
Max Observed Value 0.68 ng/mL

Normal Male

n = 10 normal fertile males

T/C Range 4.15 – 10.83
SP10 Conc. Range 62.77 – 3,076.95 ng/mL
Mean Concentration 1,734.57 ng/mL
Min Observed Value 62.77 ng/mL
Complete clinical separation achieved. All azoospermic samples clustered below 0.68 ng/mL; all normal male samples were detected above 62 ng/mL — a minimum observed gap of >91× between the two groups, with a mean concentration difference of approximately 9,700-fold. No overlap was observed.

Applications

The SP10 antibody pair is validated across multiple IVD formats and development contexts.

Male Fertility Rapid Tests

Quantitative or semi-quantitative FIA cassettes and strips for point-of-care male fertility screening. Compatible with standard fluorescence readers at clinics and home-use settings.

ELISA Kit Development

The antibody pair is validated for sandwich ELISA format, enabling quantitative measurement in research or clinical laboratory settings where higher throughput is required.

OEM Raw Material Supply

Capture and detection antibodies are available in bulk for licensed IVD manufacturers. Sekbio supports full OEM integration with consistent lot-to-lot performance and ISO 13485-compliant supply chain.

Clinical & Reproductive Research

Objective, quantitative SP10 measurement for semen quality studies, biomarker correlation research, and male infertility investigation — without the subjectivity of manual sperm counting.

Ready to Integrate SP10 Into Your Platform?

Request the full technical datasheet, antibody pair specifications, or discuss OEM supply and partnership arrangements with our team.

Guangming District, Shenzhen, China